Growth Metrics

Arrowhead Pharmaceuticals (ARWR) EPS (Weighted Average and Diluted) (2017 - 2025)

Historic EPS (Weighted Average and Diluted) for Arrowhead Pharmaceuticals (ARWR) over the last 12 years, with Q4 2025 value amounting to $0.22.

  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) rose 11582.73% to $0.22 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.53, marking a year-over-year increase of 12965.12%. This contributed to the annual value of $0.23 for FY2025, which is 10442.32% up from last year.
  • According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) is $0.22, which was up 11582.73% from $0.12 recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $2.75 in Q1 2025 and a low of -$1.45 during Q3 2024
  • Over the past 5 years, Arrowhead Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.65 (recorded in 2022), while the average stood at -$0.47.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 32666.67% in 2024 and then soared by 36960.78% in 2025.
  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.6 in 2021, then surged by 35.0% to -$0.39 in 2022, then crashed by 217.95% to -$1.24 in 2023, then fell by 12.1% to -$1.39 in 2024, then surged by 115.83% to $0.22 in 2025.
  • Its last three reported values are $0.22 in Q4 2025, $0.12 for Q3 2025, and -$1.26 during Q2 2025.